High CTLA-4 expression in stromal cells independently influenced significantly better disease-specific survival in the squamous cell carcinoma subgroup, while CTLA-4 expression in metastatic lymph nodes had an independent negative prognostic impact [33]. This evidence concerns the gene CTLA4 and squamous cell carcinoma.